Reaction

Foetal Valproate Syndrome reporting signals

Last recalculated 2026-09-14T18:28:35.993900+00:00 · 100 reports · 2 co-occurring drugs

As of the last recalculation, Foetal Valproate Syndrome appears in 100 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is VALPROATE SODIUM (PRR 857.0).

Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
DrugCo-reportsPRRROR
Valproate Sodium46857.0858.9
Vigabatrin459.559.5

Related reactions

Data source: openFDA FAERS. See the OpenPV methodology and limitations.